Sawyer & Company’s Ironwood Pharmaceuticals IRWD Stock Holding History

Sawyer & Company’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,950	Closed	-$117K	–	176
2023 Q1	$117K	Sell	10,950 -19,050	-64%	-$213K	0.06%	103
2022 Q4	$372K	Sell	30,000 -11,000	-27%	-$125K	0.18%	85
2022 Q3	$425K	Hold	41,000	–	–	0.23%	79
2022 Q2	$473K	Hold	41,000	–	–	0.24%	77
2022 Q1	$516K	Hold	41,000	–	–	0.23%	77
2021 Q4	$478K	Hold	41,000	–	–	0.21%	80
2021 Q3	$535K	Hold	41,000	–	–	0.25%	77
2021 Q2	$528K	Hold	41,000	–	–	0.25%	78
2021 Q1	$458K	Hold	41,000	–	–	0.23%	78
2020 Q4	$467K	Hold	41,000	–	–	0.24%	77
2020 Q3	$369K	Hold	41,000	–	–	0.22%	77
2020 Q2	$423K	Hold	41,000	–	–	0.26%	79
2020 Q1	$414K	Hold	41,000	–	–	0.33%	72
2019 Q4	$546K	Hold	41,000	–	–	0.35%	71
2019 Q3	$352K	Hold	41,000	–	–	0.25%	84
2019 Q2	$449K	Sell	41,000 -7,954	-16%	-$89.1K	0.3%	77
2019 Q1	$555K	Hold	48,954	–	–	0.36%	72
2018 Q4	$425K	Hold	48,954	–	–	0.31%	80
2018 Q3	$757K	Hold	48,954	–	–	0.46%	65
2018 Q2	$784K	Hold	48,954	–	–	0.51%	61
2018 Q1	$633K	Hold	48,954	–	–	0.43%	68
2017 Q4	$615K	Buy	+48,954	New	+$639K	0.4%	70

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sawyer & Company's IRWD Position: Q2 2023 in Review

Sawyer & Company sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2023, closing a stake of 10,950 shares — an estimated $117K sold.

Sawyer & Company first reported a position in IRWD in Q4 2017 and held it in 22 quarters. The position peaked at $784K in Q2 2018. 252 funds tracked by Wall St. Rank hold IRWD as of Q2 2023.

Sawyer & Company reported no remaining Ironwood Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Sawyer & Company sold 10,950 Ironwood Pharmaceuticals shares in Q2 2023, an estimated $117K.
Sawyer & Company first reported a position in Ironwood Pharmaceuticals in Q4 2017 and held it in 22 quarters.
Sawyer & Company's Ironwood Pharmaceuticals position peaked at $784K in Q2 2018.
252 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2023.

Based on Sawyer & Company's 13F filing for Q2 2023, filed 13 Jul 2023.